Stat-Rinse

Product NDC: 63551-221
11-digit product format: 635510221
Labeler code: 63551
Product ID: 63551-221_97d8bcb3-f8f5-4d45-abfe-9fd93b820b88
Type: HUMAN OTC DRUG
Nonproprietary name: ALCOHOL
Dosage form: GEL
Route: TOPICAL
Labeler: Triad Group
Application: part333
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2000-12-01
Marketing end: 0000-00-00
Substance: ALCOHOL
Active strength: 1 mL/mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 19 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63551-221		D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-01	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-03	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-05	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-06	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-07	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-08	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-09	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-10	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-11	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-12	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-13	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-14	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-15	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-17	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-24	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-27	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-28	D	Discontinued by firm	2026-10-15
excluded package	package	63551-221	63551-221-55	D	Discontinued by firm	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 7 · 418 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-28	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-06	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-17	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-09	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-27	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-24	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-03	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-11	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-08	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-10	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-14	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-07	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-15	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-55	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63551-221-13	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-28	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-06	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-17	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-09	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-27	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-24	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-03	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-11	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-08	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-12	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-10	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-14	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-07	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-15	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-55	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-05	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63551-221-13	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-06	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-10	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-24	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-15	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-55	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-09	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-13	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-08	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-28	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-27	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-07	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-14	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63551-221-17	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63551-221-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63551-221-06	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63551-221-01	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-03	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-05	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-06	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-07	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-08	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-09	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-10	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-11	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-12	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-13	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-14	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-15	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-17	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-24	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-27	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-28	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-55	2025-04-01	Stat-Rinse 6605 Drug Facts and Label
63551-221-01	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-03	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-05	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-06	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-07	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-08	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-09	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-10	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-11	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-12	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-13	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-14	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-15	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-17	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-24	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-27	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-28	2019-10-21	Stat-Rinse 6605 Drug Facts and Label
63551-221-55	2019-10-21	Stat-Rinse 6605 Drug Facts and Label

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALCOHOL	ACTIVE INGREDIENT	3K9958V90M	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
ALCOHOL	ACTIVE MOIETY	3K9958V90M	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
CARBOMER 934	INACTIVE INGREDIENT	Z135WT9208	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	STAT-RINSE (ALCOHOL) GEL [TRIAD GROUP]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3K9958V90M	ALCOHOL	64-17-5	ALCOHOL

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Stat-Rinse 6605 Drug Facts and Label	Triad Group \| ABC Compounding Co., Inc.	2010-04-28	HUMAN OTC DRUG LABEL	1

Stat-Rinse

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#